These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 10912767

  • 1. The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients.
    Sasaguri M, Noda K, Tashiro E, Notomo J, Tsuji E, Koga M, Arakawa K.
    Hypertens Res; 2000 Jul; 23(4):317-22. PubMed ID: 10912767
    [Abstract] [Full Text] [Related]

  • 2. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
    Díez J, Laviades C, Mayor G, Gil MJ, Monreal I.
    Circulation; 1995 Mar 01; 91(5):1450-6. PubMed ID: 7867186
    [Abstract] [Full Text] [Related]

  • 3. Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension.
    Sato A, Hayashi M, Saruta T.
    Hypertens Res; 2002 Nov 01; 25(6):837-42. PubMed ID: 12484506
    [Abstract] [Full Text] [Related]

  • 4. High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients.
    Sato A, Takane H, Saruta T.
    Hypertens Res; 2001 Mar 01; 24(2):99-104. PubMed ID: 11325081
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta in hypertensives with cardiorenal damage.
    Laviades C, Varo N, Díez J.
    Hypertension; 2000 Oct 01; 36(4):517-22. PubMed ID: 11040229
    [Abstract] [Full Text] [Related]

  • 6. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
    dos Santos Moreira C, Serejo F, Alcântara P, Ramalhinho V, Braz Nogueira J.
    Rev Port Cardiol; 2015 May 01; 34(5):309-14. PubMed ID: 25958256
    [Abstract] [Full Text] [Related]

  • 7. Effects of imidapril on left ventricular mass in chronic hemodialysis patients.
    Matsumoto N, Ishimitsu T, Okamura A, Seta H, Takahashi M, Matsuoka H.
    Hypertens Res; 2006 Apr 01; 29(4):253-60. PubMed ID: 16778332
    [Abstract] [Full Text] [Related]

  • 8. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M.
    Cardiovasc Pathol; 2007 Apr 01; 16(2):69-74. PubMed ID: 17317538
    [Abstract] [Full Text] [Related]

  • 9. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
    Dahlof B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V, Aurup P, Smith RD, Johansson M, REGAAL Study Investigators.
    J Hypertens; 2002 Sep 01; 20(9):1855-64. PubMed ID: 12195129
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Maisaidi M, Zanchetti A.
    Blood Press; 2006 Sep 01; 15(2):107-15. PubMed ID: 16754274
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of delapril hydrochloride on procollagen type III amino-terminal peptide, left ventricular mass and left ventricular function in hypertensive patients.
    Matoba M, Asaji T, Matsui S, Takekoshi N.
    Jpn Circ J; 1998 Dec 01; 62(12):900-2. PubMed ID: 9890202
    [Abstract] [Full Text] [Related]

  • 12. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.
    Thürmann PA, Kenedi P, Schmidt A, Harder S, Rietbrock N.
    Circulation; 1998 Nov 10; 98(19):2037-42. PubMed ID: 9808602
    [Abstract] [Full Text] [Related]

  • 13. Effects of delapril in combination with indapamide on blood pressure and left ventricular mass in elderly hypertensive patients.
    Acanfora D, Lowenthal DT, Furgi G, Trojano L, Picone C, Nicolino A, Iannuzzi GL, Papa A, Rengo F.
    Am J Ther; 1998 Jan 10; 5(1):17-23. PubMed ID: 10099033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M, Yokokawa K, Minami M, Kano H, Yasunari K, Hanehira T, Yoshikawa J.
    Am J Med; 1999 May 10; 106(5):544-9. PubMed ID: 10335726
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats.
    Wang JM, Wang Y, Zhu ZS, Zhang MC, Zou Y, Li JJ, Li MJ, Jiang XJ, Li XY.
    Life Sci; 2004 Jun 11; 75(4):407-20. PubMed ID: 15147828
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.